Definium Therapeutics Inc (DFTX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order with rules of conduct outlined for orderly proceedings and shareholder participation.

• Cautionary note issued regarding forward-looking statements and associated risks.

• Executive officers and meeting officials introduced, including CEO, CFO, and Chief Legal Officer.

• Quorum confirmed and meeting declared duly constituted for business.

Board and executive committee updates

• Seven board nominees, all current directors, were presented for re-election to serve until the next AGM.

• No additional director nominations were received within the prescribed timeframe.

Shareholder proposals

• Shareholders voted on the election of directors, appointment of auditors, and an amendment to the 2025 Equity Incentive Plan to increase available shares by 5 million.